PCM
SNTI icon

Penserra Capital Management’s Senti Biosciences Holdings SNTI Stock Holding History

Penserra Capital Management’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-228
Closed -$4K – 1194
2022
Q2 		$4K Sell
228
-46
-17% -$3.69K ﹤0.01% 1360
2022
Q1 		$27K Buy
+274
New +$27K ﹤0.01% 1172

Other funds holding SNTI

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
IC
Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Penserra Capital Management's SNTI Position: Q3 2022 in Review

Penserra Capital Management sold out of Senti Biosciences Holdings (SNTI) in Q3 2022, closing a stake of 228 shares — an estimated $4K sold.

Penserra Capital Management first reported a position in SNTI in Q1 2022 and held it in 2 quarters. The position peaked at $27K in Q1 2022. 23 funds tracked by Wall St. Rank hold SNTI as of Q3 2022.

  • Penserra Capital Management reported no remaining Senti Biosciences Holdings position as of Q3 2022 after selling out during the quarter.
  • Penserra Capital Management sold 228 Senti Biosciences Holdings shares in Q3 2022, an estimated $4K.
  • Penserra Capital Management first reported a position in Senti Biosciences Holdings in Q1 2022 and held it in 2 quarters.
  • Penserra Capital Management's Senti Biosciences Holdings position peaked at $27K in Q1 2022.
  • 23 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q3 2022.

Based on Penserra Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.